IMI1 – Call 11

IMI1 – Call 11 was launched on 11 December 2013 with the following topics:

  • Applied public-private research enabling osteoarthritis clinical headway (approach)
  • European platform to facilitate proof of concept for prevention in Alzheimer’s disease (EPOC-AD)
  • Blood-based biomarker assays for personalised tumour therapy: value of latest circulating biomarkers
  • Zoonoses anticipation and preparedness initiative (ZAPI)
  • Generation of research tools to enable the translation of genomic discoveries into drug discovery projects
  • Epidemiology research and development of novel systemic antibacterial molecules against healthcare-associated infections due to clinically challenging Gram-negative pathogens (part of the IMI antimicrobial resistance programme New Drugs for Bad Bugs, ND4BB)
    • Subtopic A: Epidemiology research and clinical development of a novel bispecific IGG antibody, BiS4αPa, for the prevention of serious Pseudomonas aeruginosa disease
    • Subtopic B: Clinical development of a novel resistance-breaking beta-lactam antibiotic, AIC499, in combination with a beta-lactamase inhibitor (BLI) against severe bacterial infections due to Gram-negative pathogens
  • Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-CF bronchiectasis (BE)
    (part of the IMI New Drugs for Bad Bugs (ND4BB) programme)
  • Ecoriskprediction (ERP)

More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI1 Call documents page.

 

Projects

The projects resulting from IMI1 – Call 11 are:

  • APPROACH - Applied public-private research enabling osteoarthritis clinical headway
    factsheet | website
  • CANCER-ID - Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
    factsheet | website
  • COMBACTE-MAGNET - Combatting bacterial resistance in Europe - molecules against Gram negative infections
    factsheet | website
  • EPAD - European prevention of Alzheimer’s dementia consortium
    factsheet | website
  • iABC - Inhaled antibiotics in bronchiectasis and cystic fibrosis
    factsheet | website
  • iPiE - Intelligent Assessment of Pharmaceuticals in the Environment
    factsheet | website
  • ULTRA-DD - Unrestricted leveraging of targets for research advancement and drug discovery
    factsheet | website
  • ZAPI - Zoonotic anticipation and preparedness initiative
    factsheet | website